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Abstract: To determine xerostomia-related frequency, factors, salivary 
flow rates and Oral Health-Related Quality of Life (OHRQoL) of patients 
attending the Universidad Andrés Bello Dental School Clinic, in the 
city of Viña del Mar, Chile. The study involved 566 patients assessed 
with xerostomia, based on a single standardized questionnaire. The 
severity and impact of xerostomia on OHRQoL was assessed using a 
visual analogue scale (VAS) and the short version of the Oral Health 
Impact Profile Questionnaire (OHIP-14sp), respectively. Stimulated 
and non-stimulated salivary flow rates were obtained from a sample 
of patients. Xerostomia was reported in 61 patients (10.8%), comprising 
50 women (83.3%) and 11 men (16.7%) (p < 0.013). The prevalence 
was 13% among the women and 6.1% among the men. Gender, age 
and medication were found to be independent risk factors for the 
development of xerostomia. Hyposalivation was found in 10 of 
the 35 patients with xerostomia (28.6%) and in 2 patients without it 
(p < 0.011). Patients with xerostomia had a reduced OHRQoL, compared 
with patients without xerostomia, as shown by the total OHIP-14sp 
score (p < 0.001). Xerostomia was a common, potentially debilitating 
condition with a major impact on the OHRQoL of a patient population 
attending a university-based dental clinic. Hyposalivation was present 
in almost 30% of the patients who complained of xerostomia. It is 
important that general dentists be aware of this condition, so that they 
can provide patients with a good diagnosis, treatment and follow-up. 
Keywords: Xerostomia; Quality of Life.
Introduction
Saliva is one of the most essential fluids of the body. Patients never 
realize how important it is until it is missing, and ordinary things, like 
eating or speaking, become a daily problem. The sensation of dry mouth, 
or xerostomia, is a common complaint in clinical practice. Xerostomia 
is defined as “a subjective sensation of dry mouth,” which is usually 
correlated with low salivary flow rates (hyposalivation). Nevertheless, 
many patients have a dry mouth sensation with normal salivary flow 
rates; therefore, xerostomia does not necessary reflect salivary gland 
hypofunction. Hyposalivation is defined as an objective reduction in 
the salivary flow rate. Saliva is usually categorized as unstimulated 
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(resting) or stimulated. Unstimulated saliva reflects 
the basal flow rate aimed at protecting the oral 
mucosa, and has been reported to range from about 
0.29 ml/min to 0.4l ml/min. Stimulated saliva helps 
with mastication and digestion, and has been reported 
to be between 1-2 ml/min.1
Xerostomia is a common problem. Its prevalence 
is difficult to determine, because it varies between 
different geographical zones and age groups, and 
because of differences in the inclusion criteria and 
methodology of studies.2 Epidemiological studies 
have reported its prevalence to be between 0.9% 
and 64.8%.3
Many factors have been associated with xerostomia. 
The most common causes are:4,5,6,7,8,9 
a. Medications (more than 400 drugs are associated 
with xerostomia as a side effect);
b. Psychological conditions, such as stress and 
anxiety;
c. Salivary gland disorders, such as Sjögren’s 
syndrome;
d. Head and neck radiotherapy.
Xerostomia is more common in women, and its 
prevalence is highest in the sixth decade, probably 
because of an increase in drug intake, due to chronic 
disorders, such as hypertension, diabetes, depression, 
etc.;10,11 however, there are reports that age itself acts 
as a risk factor for xerostomia. Field et al.12 reported 
that the use of medications and age independently 
increases the likelihood of developing xerostomia 
1.24 times for every 10 years of age. The same authors 
also reported almost four times greater prevalence 
of xerostomia in patients taking medications (28%), 
compared with those not taking any (7.5%). It has 
been reported that not only the type of drug, but 
also the number of drugs taken (polypharmacy, 
or simultaneous, multiple use of drugs) increases 
the likelihood of developing xerostomia, which is a 
common feature in elderly patients.13 
Dry mouth sensation has many effects on oral 
health, and may have a negative impact on quality 
of life. Patients with xerostomia may complain of 
a burning sensation, abnormal taste, dysarthria, 
dysphagia, dysgeusia, halitosis and lack of retention 
of dentures. Examination may demonstrate oral 
dryness, thickening of saliva, evidence of candidal 
infection (usually angular cheilitis or erythematous 
candidiasis), tongue fissuring and depapillation, 
cervical caries and halitosis.14 It has been documented 
that xerostomia is a good predictor of root caries 
development in elderly patients.15
Little attention has been given to the impact 
of xerostomia on quality of life, in comparison 
with the effects of caries and periodontal disease. 
A study conducted in Canada, which evaluated oral 
health-related quality of life (OHRQoL) in patients 
with dry mouth, reported that xerostomia had an 
important influence on well-being and quality of life. 
Similar results have been published elsewhere.16,17
Although associated factors, salivary flow rates 
and prevalence of xerostomia have been reported in 
many studies, these features have strong geographical 
variations, and none of these studies were conducted 
among Chilean patients. Furthermore, OHRQoL in 
patients with xerostomia has not been widely studied, 
even though xerostomia is a common clinical condition 
with a growing prevalence. 
The aim of this study was to determine the 
xerostomia-related frequency, factors, salivary flow 
rates and OHRQoL of patients attending a dental 
school clinic in the city of Viña del Mar, Chile. To our 
knowledge, this is the first study that has investigated 
the frequency, causes and impact on quality of life 
of xerostomia in a Chilean population. 
Methodology
Study population
The sample size was calculated with a power of 
90%, a confidence level of 95%, an estimated prevalence 
of 15% and an error of 5%. The minimum number of 
required participants was 536. The study involved 
566 patients who attended the dental clinic of the 
Universidad Andrés Bello School of Dentistry in 
Viña del Mar, Chile, between April and November 
2014. Approval was obtained from the scientific 
research ethics committee of the Universidad 
Andrés Bello School of Dentistry prior to the study. 
Participants in this study were recruited when they 
attended their dental appointment, and had to be over 
eighteen years old to be included. Every patient over 
eighteen attending the dental clinic during the study 
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recruitment time was invited to participate. Eligible 
individuals who agreed to participate were required 
to sign a consent form before being interviewed. 
This research was conducted in full accordance 
with the World Medical Association Declaration 
of Helsinki. The data were collected by personal 
interview conducted at the dental clinic, and were 
recorded in a specifically designed questionnaire. 
Measurements 
Xerostomia and related factors
The questionnaire included the following variables: 
gender, age, systemic diseases, menopause, drugs 
(type, number and time of use), smoking habits 
(measured as number of cigarettes consumed per 
day) and presence of xerostomia.
The following question was asked to evaluate the 
presence of xerostomia: “How often do you feel that 
your mouth is dry?” Participants could select from 
the following answers: ‘never,’ ‘sometimes,’ ‘usually’ 
or ‘always.’ Those who answered ‘usually’ or ‘always’ 
were considered as suffering from xerostomia.18,19,20 
The severity of xerostomia was measured using 
a visual analogue scale (VAS). The visual analogue 
scale consisted of a 10-cm horizontal line with 0 and 10 
marked on each extreme. Zero reflected no xerostomia 
and ten, the worst degree of xerostomia. Patients 
were asked to draw a vertical line perpendicular 
to this horizontal line to reflect their symptom 
severity.  The distance from the vertical line to zero 
was measured and recorded to determine the value 
for each patient.21,22
Evaluation of xerostomia impact on quality of life
Oral health-related quality of life was assessed 
using the Spanish version of the oral health impact 
profile-14 questionnaire (OHIP-14sp). OHIP-14 is a 
14-item questionnaire designed to measure self-reported 
functional limitation, discomfort and disability 
attributed to oral conditions.23 Although the OHIP-14sp 
is a short questionnaire, it has been found to be 
reliable and sensitive to changes, and to have adequate 
cross-cultural consistency.24 OHIP-14sp was evaluated 
according to the following domains: functional 
limitation, physical pain, psychological discomfort, 
physical incapacity, psychological incapacity, social 
incapacity, and social disadvantage. The answers 
were assessed using a Likert type evaluation scale 
with five points: never = 0; rarely = 1; sometimes = 2; 
repeatedly = 3; always = 4. The OHIP-14sp scale ranges 
from 0 to 56. The lowest scores represent a satisfactory 
perception of an individual’s oral conditions, and, 
therefore, higher satisfaction and better quality of life. 
Evaluation of salivary flow rate
A case control study was conducted to correlate 
the presence of xerostomia and salivary flow rate. 
All the 61 patients who complained of xerostomia 
were invited to participate in this part of the study. 
However, patients who had any disease associated with 
xerostomia (such as Sjögren’s Syndrome, hepatitis C, 
HIV, etc.) were excluded. Thirty-five patients who had 
xerostomia and met the inclusion criteria accepted to 
participate in this part of the study, and were assigned 
to the xerostomia group. Thirty-five patients without 
xerostomia were invited to compose the control group. 
These were selected with a simple random sampling 
method using Microsoft Excel 2011, among the patients 
who answered ‘never’ to the xerostomia question. 
Two investigators were responsible for selecting these 
patients, and they were not blinded to the diagnosis. 
Additionally, these patients were asked to answer 
five questions about presence or absence of oral 
symptoms (eating impairment, burning sensation, 
abnormal taste, self-perceived halitosis and need to 
drink liquids to aid in swallowing foods). 
Sialometry was performed using the spitting 
method. Patients were instructed to refrain from 
eating, drinking, smoking and engaging in oral 
hygiene activit ies for a minimum of 60 min 
before the procedure. Samples were collected in 
the morning hours, between 9:30 and 11:30 am, 
always in the same room under similar room 
temperatures. Collection time for stimulated and 
non-stimulated whole salivary flow was 5 minutes. 
First, non-stimulated whole saliva was collected. 
Patients were instructed to spit into a tube for five 
minutes, and the amount of saliva was measured 
using a graduated syringe. Stimulated whole saliva 
was collected after an interval of 3 minutes using 
the mastication method. Subjects were asked to 
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chew a wax cube 15 mm x 10 mm for 1 minute at 
their own pace, and then to spit into a tube for 
5 minutes. Wax residue was eliminated using filter 
paper before quantification using a graduated 
syringe. The cut-off values for hyposalivation were 
based on previous literature, and were as following: 
below 0.1 ml/min for unstimulated whole salivary 
flow and below 0.5 ml/min for stimulated whole 
salivary flow.1 The Lin’s concordance agreement 
between the examiners was 0.9. 
Statistical analysis
The data was analyzed using Microsoft Excel 2011, 
R-Cran 3.0.1 (version 64x) and IBM SPSS Statistics, 
version 22 for Windows. 
Xerostomia analysis: The Fisher exact test and the 
Wilcoxon rank sum test were used to analyze qualitative 
and quantitative variables, respectively. Logistic 
regression was used to determine associated factors. 
Salivary flow rates, hyposalivation and oral 
symptoms analysis: The Wilcoxon rank sum test was 
applied for quantitative variables, and the chi-square 
test was used for qualitative variables. 
P-values below 0.05 were considered statistically 
significant.
Results
The study population comprised 566 participants 
(386 women and 180 men) aged 18 to 83, with a mean 
age of 46 years (SD 15.59).
Xerostomia was reported by 61 patients (10.8%). 
Of these, 50 were women (83.3%) and 11 were men (16.7%) 
(p < 0.013). The prevalence of xerostomia was 13% among 
the women [CI 95%: 9.8%-16.6%] and 6.1% among the 
men [CI 95%: 3.1%-10.7%]. The highest prevalence was 
seen in patients aged 68 to 77 years (33.3%), followed 
by patients aged 78 to 83 (22.27%) (Table 1). 
A total of 372 patients of the sample population 
had a systemic disease, and 194 were systemically 
well. Fifty patients with xerostomia (82%) had a 
systemic disease, and 11 (18%) were systemically 
well. Cardiovascular diseases, psychological illness, 
gastrointestinal diseases and allergies were the most 
commonly reported diseases. Nevertheless, there 
was no statistical association between the presence 
of a systemic disease and xerostomia (p > 0.442). 
The presence of menopause was not statistically 
associated with xerostomia (p = 0.052). Nevertheless, 
a higher prevalence of xerostomia was found among 
menopausal women (17.97% vs 10.47%).
Of the 566 patients, 42.4% (n = 240) reported 
taking some type of medication. The prevalence of 
xerostomia in these patients was 17.92%. The prevalence 
of xerostomia among the patients not taking medication 
was 5.52%. This difference was statistically significant 
(p < 0.001). Of the 61 patients with xerostomia, 70.5% 
(n = 43) were taking one or more medications at the time 
of the study. A statistically significant association was 
found between the use of antidepressants (p < 0.001), 
antihypertensives (p < 0.001) and antihistamines 
(p = 0.045) with xerostomia. 
Table 1. Prevalence of xerostomia by age group.
Age
Presence of xerostomia
Total
Yes No
no. % no. % no. %
18–27 6 5.94 95 94.06 101 100.00
28–37 7 7.87 82 92.13 89 100.00
38–47 12 10.62 101 89.38 113 100.00
48–57 15 10.87 123 89.13 138 100.00
58–67 7 8.64 74 91.36 81 100.00
68–77 11 33.33 22 66.67 33 100.00
78–87 3 27.27 8 72.73 11 100.00
Total 61 10.78 505 89.22 566 100.00
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Associated factors for xerostomia
Age alone was found to be a factor associated with 
xerostomia. For every one-year increment, the chances 
of having xerostomia increased 1.01 times (p < 0.001). 
Males were found to have a 1.56 times smaller chance of 
having xerostomia, compared with females (p < 0.012). 
The chance of having xerostomia increased 1.12 times 
with each additional medication being taken (p = 0.005). 
Systemic diseases and smoking habit were not found to 
be associated factors in xerostomia development (Table 2). 
Oral health-related quality of life
As shown in Table 3, patients with xerostomia 
had a significantly higher total OHIP-14sp score 
than patients without xerostomia (20.1 ± 14.32 and 
12.7 ± 12.9 respectively, p < 0.001). Patients with 
xerostomia scored higher on every domain of the 
OHIP-14sp (p < 0.005) than patients without it, 
with a higher impact on psychological discomfort, 
psychological incapacity and physical pain (4.1, 3.8 
and 3.4, respectively) (Table 4). 
Table 2. Logistic regression for associated factor analysis.
Variables 
Degrees of 
freedom
Deviance
Residual degrees 
of freedom
Residual deviance p-value
Age 1 10.123 564 376.83 0.001464
Gender 1 6.189 563 370.65 0.012853
Presence of systemic disease 1 0.591 562 370.05 0.442083
Nº. of medications 1 7.749 561 362.31 0.005373
Nº of cigarettes 1 0.892 560 361.41 0.344942
Table 3. Patient-reported symptoms.
Variable
Frequency n(%)
p-value
Xerostomia Control
Eating impairment 7 (20) 0 (0) < 0.011
Need to drink liquids to aid in swallowing foods 9 (25) 0 (0) > 0.057
Burning sensation 7 (20) 1 (2.9) > 0.055
Abnormal taste 12 (34.3) 3 (8.6) < 0.009
Self-perceived halitosis 14 (40) 8 (22.9) > 0.122
Table 4. Comparison of the OHIP-14sp scores for xerostomia vs. non-xerostomia patients.
OHIP domains
With xerostomia Without xerostomia
p-value
Mean Standard deviation Mean Standard deviation
Dom.1 Functional limitation 2.03 1.59 0.97 1.4 < 0.001
Dom.2 Physical pain 3.43 2.01 2.3 1.87 < 0.001
Dom.3 Psychological discomfort 4.15 2.12 3.28 2.07 < 0.004
Dom.4 Physical incapacity 2.51 2.09 1.42 1.87 < 0.001
Dom.5 Psychological incapacity 3.80 2.18 2.33 2.16 < 0.001
Dom.6 Social incapacity 2.13 2.06 1.26 1.84 < 0.001
Dom.7 Social disadvantage 2 2.27 1.15 1.78 < 0.001
Total OHIP 20.05 14.32 12.71 12.99  -
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Cronbach’s alpha coefficient was 0.879 for the OHIP-14, 
considered a good internal consistency reliability score.25
Salivary flow rates / hyposalivation
Seventy patients (35 with and 35 without xerostomia) 
were divided into two groups: a xerostomia and a control 
group (35 patients in each group). The xerostomia group 
consisted of 29 females and 6 males, with a mean age 
of 53.8 ± 16.6 years. The control group consisted of 
24 females and 11 males with a mean age of 46.6 ± 14.6. 
Mean non-stimulated and stimulated whole salivary 
flow was 0.1 ± 0.28 ml/min and 1.53 ± 1.03 ml/min for the 
xerostomia group, respectively, and 0.42 ± 0.33 ml/min 
and 1.53 ± 0.96 ml/min for the control group, respectively. 
No statistically significant differences were found 
between the groups, neither for non-stimulated nor 
for stimulated whole salivary flow rates.  
Non-stimulated hyposalivation (defined above as a 
salivary flow rate below 0.1 ml/min) was found in 28.6% 
(n = 10) of the xerostomia group patients, and in 5.7% 
(n = 2) of the control group patients.  This difference 
was statistically significant (p < 0.011). Stimulated 
hyposalivation (defined above as a salivary flow rate 
below 0.5 ml/min) was found in 14.3% (n = 5) of the 
xerostomia group patients, and in 8.6% (n = 3) of the 
control group patients. These values were not statistically 
significant (p > 0.452).
Oral symptoms
Eating impairment and abnormal taste sensation 
were more frequent among patients with xerostomia, 
with statistically significant differences (p < 0.01 and 
p < 0.009, respectively). Although burning sensation, 
self-perceived halitosis and the need to drink liquids 
to aid in swallowing foods, were more common among 
the xerostomia group, the value was not statistically 
significant (Table 3).
Discussion
The prevalence of xerostomia in a Chilean 
population attending a dental school clinic in Viña 
del Mar, Chile, was 10.8%. Orellana et al. conducted a 
systematic review in which they reported a prevalence 
of xerostomia between 0.9% and 64.8%, but most of 
the reports involved people over 50 years of age.3 
In accordance with the present results, Hahnel et al.25 
reported a prevalence of 16%, and Field et al.,12 one of 
12.7%, in a general population. In a Swedish study, the 
authors reported a 22% prevalence of xerostomia in 
patients aged 20 to 60 years.27 Nederfors et al. estimated 
the prevalence in the Swedish population to be 21.3% 
for men and 27.3% for women.28 Österberg et al.29 and 
Locker30 reported prevalence rates of 21% and 22.5% 
for men and women over 60 years, respectively.
Because the dry mouth sensation is a subjective 
symptom, it is difficult to compare prevalence rates 
among studies, due to the different methods of 
assessment.  The fact that there is no “single universal 
question” that could be asked to assess xerostomia 
makes comparisons among different studies difficult. 
It is important when comparing prevalence rates 
among studies to consider the age range of the study 
population. Most of the studies that report prevalence 
rates higher than the present results were carried out in 
groups of older patient (over 50 or over 60 years of age), 
therefore correlating with more risk factors, and possibly 
explaining the higher prevalence rates. Nevertheless, 
these studies do not afford precise information on how 
common this problem is in the general population. 
It is widely reported that xerostomia is more 
common among women.3,28 Many have argued that this 
may be because women take more medications than 
men, but it has been found that even non-medicated 
women have a higher prevalence of xerostomia than 
men.2 A recent systematic review3 indicated that the 
prevalence of xerostomia in females is 8% higher 
than in males.  The results of the present study 
corroborate this, showing a difference of 7% between 
the genders (13% in women and 6.1% in men).  Based 
on the present results, men have a 1.56 times smaller 
chance of presenting with xerostomia than women. 
Similarly, Thomson et al. reported xerostomia to be 
1.62 times more likely to occur in women than in men.31
Several studies have reported xerostomia to be 
more frequently related with older age, especially in 
populations over 60 years of age.2,26 The explanation 
may be that age acts as a risk factor, or it could be that 
elderly patients have more risk factors than younger 
people. Older age is associated with more chronic 
diseases, which is associated with more drug intake, 
and this is the most common cause of dry mouth.
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It has been reported that age per se could act as a 
risk factor for the development of dry mouth, since 
old people may have diminished salivary gland 
secretion, due to salivary gland atrophy.28 An English 
study studied over 1,100 patients to determine risk 
factors for xerostomia. The authors concluded that 
age in itself increases the risk of having dry mouth 
1.24 times for every 10 years of age.12 The present 
study also found age to be a risk factor for xerostomia. 
Every additional year of life increases the chances of 
having dry mouth 1.01 times. 
Although age in itself can be considered a risk 
factor, a better predictor of the development of 
xerostomia is the use of medication. Based on the 
results of the present study, dry mouth sensation is 
more common in medicated patients (17.92% vs. 5.52%), 
and the likelihood of having xerostomia increases 
1.12 times for each additional medication taken. Han 
et al. reported a 33.5% prevalence of xerostomia in 
patients with a daily intake of at least three drugs, 
and a 67% prevalence in patients who take more than 
seven drugs a day.2 Yuan et al. found an increase in 
the prevalence of dry mouth when patients took 
more than three medications.32 Field et al.12 concluded 
that medication is a highly significant risk factor for 
having a dry mouth, and is a better predictor of risk 
status than either age or gender. This corroborates the 
study by Nederfors et al.,28  who found a very strong 
association between polypharmacy and xerostomia.
Corroborating the results of this report, a recent 
systematic review on medication-induced salivary 
gland dysfunction concluded that xerostomia is more 
common among medicated persons than among 
non-medicated persons and that the frequency of 
xerostomia is mostly related to the dose and number 
of medications.6
It is reported that menopause may act as a possible 
risk factor for reporting a dry mouth.10,33 Although the 
present report found a dry mouth prevalence of 17.97% 
among menopausal women, this was not statistically 
significant when compared with non-menopausal 
women (p = 0.052). 
Patients with xerostomia have a more reduced 
OHRQoL than patients without xerostomia, as shown 
in the total OHIP-14sp score. The highest impact 
was detected for the domains of psychological 
discomfort, psychological incapacity and physical 
pain. Nevertheless, the utility of the OHIP-14sp in 
detecting changes in the different sub-scales has been 
questioned;34 thus, this result should be regarded with 
caution. According to Hopcraft et al., patients with 
severe xerostomia are 2.3 to 4.9 times more likely to 
have a negative experience and negative impact on 
quality of life.35 A Japanese study concluded that 
xerostomia is independently associated with a higher 
impact on OHRQoL.36 According to some authors, 
xerostomia affects quality of life by interfering with 
speech, taste and mood.17 Patients with xerostomia 
are more prone to having dental caries, periodontal 
disease, burning sensation and lack of retention 
of dentures, which are also related with a reduced 
OHRQoL.35 Hanel et al.26 reported a positive correlation 
between the severity of xerostomia and impact on 
OHRQoL – more severe symptoms are associated 
with a higher impact on OHRQoL.
Although there were no significant differences 
between the non-stimulated and the stimulated 
whole salivary flow rates (measured in ml/min) 
between patients with and without xerostomia, 
there was a significant association between 
non-stimulated hyposalivation and xerostomia 
(p < 0.01). This is important in clinical practice; the 
present results indicate that almost 30% of patients 
who complain of xerostomia of non-organic cause 
will have a non-stimulated salivary flow rate below 
0.1 ml/min, which could have a detrimental effect 
on the oral cavity.
Eating impairment and abnormal taste sensation 
were associated with xerostomia, as corroborated 
by Lee et al.37 Although burning sensation and the 
need to drink liquids to aid in swallowing foods 
were not statistically associated with xerostomia in 
this study, the p values were close to significance. 
The relation between xerostomia and the need to 
drink liquids to aid in swallowing foods was not 
found to be statistically significant. It is noteworthy 
that this concept is used in many studies as a single 
question to diagnose xerostomia. Nonetheless, study 
results suggest that this question should no longer be 
used to diagnose xerostomia, since it is not strongly 
associated with xerostomia, if at all. A larger sample 
size is needed to clarify this. 
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This study has two limitations. First, our population 
was recruited from a university dental clinic, suggesting 
that the prevalence of xerostomia might be overestimated. 
Therefore, more population-based studies are warranted. 
Second, we recognize that it would have been ideal 
to assess xerostomia using a specially designed 
questionnaire, such as the xerostomia inventory, but 
the validated Spanish version of this questionnaire was 
not available when this study was conducted. 
Conclusion
Dry mouth sensation is a common problem among 
Chilean patients, with a prevalence of 10.8%. Risk 
factors for dry mouth are gender, age, and, most 
importantly, the type and number of medications 
taken. Non-stimulated hyposalivation may be present 
in about 30% of patients with a non-organic cause 
of xerostomia. Dry mouth sensation is a potentially 
debilitating condition that can considerably affect the 
OHRQoL. It is important that general dentists be aware 
of this condition and understand its possible causes 
and risk factors, so that they can provide patients with 
a good diagnosis, treatment and follow-up. 
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